| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 605743 | 75371 | MAGNESIA LAINCO 2,4 g SUSPENSION ORAL | MAGNESIA LAINCO 2,4 g SUSPENSION ORAL, 200 sobres de 12 ml | 2.400 mg | 35 | 200 | 64 | 200 sobres de 12 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75371/75371_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75371/75371_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | 1614 | 2012-02-01 | 1 | 1 | 1 | 2012-02-01 | 2012-02-01 | 1 | 2012-05-07 | View Edit Delete | ||||||||||||
| 607322 | 58329 | ALMAX FORTE 1,5 g SUSPENSION ORAL | ALMAX FORTE 1,5 g SUSPENSION ORAL,506 sobres | 1,5 g | 35 | 506 | 64 | 506 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58329/58329_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58329/58329_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 1989-12-01 | 1 | 1 | 1 | 1989-12-01 | 2019-11-27 | 1 | 2020-01-13 | View Edit Delete | ||||||||||||
| 632661 | 64114 | AMOXICILINA/ACIDO CLAVULANICO NORMON 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG | AMOXICILINA/ACIDO CLAVULANICO NORMON 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG , 500 sobres | 875 mg/125 mg | 35 | 500 | 64 | 500 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64114/64114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64114/64114_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2001-07-23 | 1 | 1 | 1 | 2001-07-23 | 2001-07-23 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 650605 | 66540 | MAGNESIA CINFA 2,4 g SUSPENSION ORAL | MAGNESIA CINFA 2,4 g SUSPENSION ORAL , 14 sobres | 2.400 mg | 35 | 14 | 64 | 14 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66540/66540_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66540/66540_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2005-01-21 | 1 | 1 | 1 | 2005-01-21 | 2005-01-21 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 653585 | 55397 | ALMAX 1g/7,5 ml SUSPENSION ORAL | ALMAX 1g/7,5 ml SUSPENSION ORAL , 1 frasco de 225 ml | 1.000 mg/7,5 ml | 6 | 225 | 26 | 1 frasco de 225 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/55397/55397_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/55397/55397_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 1982-01-01 | 1 | 1 | 1 | 1982-01-01 | 2011-11-29 | 1 | 2012-01-02 | 946509 | View Edit Delete | |||||||||||
| 661467 | 53626 | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG , 1 frasco de 120 ml | 250 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/53626/53626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/53626/53626_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | 2367 | 1976-02-01 | 1 | 1 | 1 | 1976-02-01 | 2008-09-26 | 1 | 2011-02-08 | 939314 | View Edit Delete | |||||||||||
| 668830 | 61670 | BUDESONIDA NASAL ALDO-UNIÓN 100 microgramos/dosis SUSPENSION PARA PULVERIZACION NASAL | BUDESONIDA NASAL ALDO-UNIÓN 100 microgramos/dosis SUSPENSION PARA PULVERIZACION NASAL , 1 envase pulverizador de 200 dosis | 100 microgramos/dosis | 45 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61670/61670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61670/61670_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 1998-02-01 | 1 | 1 | 1 | 1998-02-01 | 1998-02-01 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 669887 | 57849 | FLUTOX 3,54 mg/ml JARABE | FLUTOX 3,54 mg/ml JARABE , 1 frasco de 200 ml | 3,54 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57849/57849_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57849/57849_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29563 | 29563 | 1988-12-01 | 1 | 1 | 1 | 1988-12-01 | 2001-01-17 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 682676 | 74511 | CLOPERASTINA KERN PHARMA 3,54 mg/ml JARABE | CLOPERASTINA KERN PHARMA 3,54 mg/ml JARABE, 1 frasco de 200 ml | 3,54 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74511/74511_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74511/74511_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2011-08-01 | 1 | 1 | 1 | 2011-08-01 | 2011-08-01 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 687425 | 75371 | MAGNESIA LAINCO 2,4 g SUSPENSION ORAL | MAGNESIA LAINCO 2,4 g SUSPENSION ORAL, 14 sobres de 12 ml | 2.400 mg | 35 | 14 | 64 | 14 sobres de 12 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75371/75371_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75371/75371_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | 1614 | 2012-02-01 | 1 | 1 | 1 | 2012-02-01 | 2012-02-01 | 1 | 2012-05-07 | View Edit Delete | ||||||||||||
| 688710 | 06378017 | INOVELON 40 mg/ml SUSPENSION ORAL | INOVELON 40 mg/ml SUSPENSION ORAL, 1 frasco de 460 ml | 40 mg/ml | 6 | 460 | 26 | 1 frasco de 460 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06378017/06378017_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06378017/06378017_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34732 | 32215 | 2012-03-20 | 1 | 1 | 1 | 2012-03-20 | 2012-03-20 | 1 | 2012-12-28 | View Edit Delete | ||||||||||||
| 689679 | 60483 | FLIXONASE 50 microgramos/pulverizacion, SUSPENSION PARA PULVERIZACION NASAL | FLIXONASE 50 microgramos/pulverizacion, SUSPENSION PARA PULVERIZACION NASAL , 1 frasco de 120 dosis | 50 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60483/60483_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60483/60483_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | 3732 | 1997-11-01 | 1 | 1 | 1 | 1997-11-01 | 1997-11-03 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 693493 | 64113 | AMOXICILINA/ACIDO CLAVULANICO NORMON 500 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG | AMOXICILINA/ACIDO CLAVULANICO NORMON 500 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG, 30 sobres | 500 mg/ 125 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64113/64113_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64113/64113_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2001-07-23 | 1 | 1 | 1 | 2001-07-23 | 2012-09-27 | 1 | 2013-05-24 | View Edit Delete | ||||||||||||
| 693494 | 64114 | AMOXICILINA/ACIDO CLAVULANICO NORMON 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG | AMOXICILINA/ACIDO CLAVULANICO NORMON 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG , 30 sobres | 875 mg/125 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64114/64114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64114/64114_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2001-07-23 | 1 | 1 | 1 | 2001-07-23 | 2012-09-27 | 1 | 2013-05-24 | View Edit Delete | ||||||||||||
| 693495 | 64114 | AMOXICILINA/ACIDO CLAVULANICO NORMON 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG | AMOXICILINA/ACIDO CLAVULANICO NORMON 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG , 20 sobres | 875 mg/125 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64114/64114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64114/64114_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2001-07-23 | 1 | 1 | 1 | 2001-07-23 | 2012-09-27 | 1 | 2013-05-24 | View Edit Delete | ||||||||||||
| 693703 | 76618 | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL , frasco de 23 g (120 pulverizaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | frasco de 23 g (120 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76618/76618_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76618/76618_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2013-04-24 | 1 | 1 | 1 | 2013-04-24 | 2013-04-24 | 1 | 2014-11-11 | View Edit Delete | ||||||||||||
| 693739 | 56281 | SEKISAN 3,54 mg/ml JARABE | SEKISAN 3,54 mg/ml JARABE , 1 frasco de 200 ml | 3,54 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56281/56281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56281/56281_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 945 | 1984-05-29 | 1 | 1 | 1 | 1984-05-29 | 1994-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 694746 | 53626 | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG , 1 frasco de 40 ml | 250 mg/5 ml | 6 | 80 | 26 | 1 frasco de 40 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/53626/53626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/53626/53626_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | 2367 | 1976-02-01 | 1 | 1 | 1 | 1976-02-01 | 2012-11-19 | 1 | 2013-06-07 | View Edit Delete | ||||||||||||
| 695268 | 76859 | MOMETASONA SANDOZ 50 MICROGRAMOS/DOSIS SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA SANDOZ 50 MICROGRAMOS/DOSIS SUSPENSION PARA PULVERIZACION NASAL , 1 envase de 18 g (140 nebulizaciones) | 50 microgramos/dosis | 65 | 140 | 31 | 1 envase de 18 g (140 nebulizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76859/76859_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76859/76859_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2013-05-06 | 1 | 1 | 1 | 2013-08-27 | 2013-08-27 | 1 | 2014-03-05 | View Edit Delete | ||||||||||||
| 696445 | 106380006 | PREZISTA 100 MG/ML SUSPENSION ORAL | PREZISTA 100 MG/ML SUSPENSION ORAL , 1 frasco de 200 ml | 10 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/106380006/106380006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/106380006/106380006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | 71027 | 2013-02-01 | 1 | 1 | 1 | 2013-02-01 | 2013-02-01 | 1 | 2013-09-02 | View Edit Delete | ||||||||||||
| 699638 | 77974 | MOMETASONA FUROATO TEVA 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA FUROATO TEVA 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL , 1x140 pulverizaciones | 50 microgramos/dosis | 6 | 140 | 31 | 1x140 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77974/77974_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77974/77974_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2013-11-18 | 1 | 1 | 1 | 2013-11-18 | 2013-12-03 | 1 | 2014-05-27 | View Edit Delete | ||||||||||||
| 700669 | 34388 | FURANTOINA 10 mg/ml SUSPENSION ORAL | FURANTOINA 10 mg/ml SUSPENSION ORAL, 1 frasco de 80 ml | 10 mg/ml | 6 | 80 | 26 | 1 frasco de 80 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/34388/34388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/34388/34388_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 1960-09-01 | 1 | 1 | 1 | 1960-09-01 | 2016-12-19 | 1 | 2013-01-03 | 760777, 653419, 663413, 654195 | View Edit Delete | |||||||||||
| 700671 | 53775 | LOMPER 20 mg/ml SUSPENSION ORAL | LOMPER 20 mg/ml SUSPENSION ORAL , 1 frasco de 30 ml | 20 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/53775/53775_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/53775/53775_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29206 | 29206 | 1976-11-01 | 1 | 1 | 1 | 1976-11-01 | 2017-03-03 | 1 | 2013-01-03 | 688689, 999872, 654270 | View Edit Delete | |||||||||||
| 702772 | 78859 | ALGIDRIN PEDIATRICO 20 MG/ML SUSPENSION ORAL | ALGIDRIN PEDIATRICO 20 MG/ML SUSPENSION ORAL , 200 ml | 20 mg/ml | 6 | 200 | 26 | 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78859/78859_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78859/78859_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | 27143 | 2014-06-30 | 1 | 1 | 1 | 2014-06-30 | 2014-06-30 | 1 | 2015-04-17 | View Edit Delete | ||||||||||||
| 703001 | 78899 | MOMETASONA FUROATO CIPLA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA FUROATO CIPLA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL , 140 pulverizaciones | 50 microgramos/dosis | 6 | 140 | 31 | 140 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78899/78899_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78899/78899_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68210 | 23885 | 2014-07-14 | 1 | 1 | 1 | 2014-07-14 | 2014-07-14 | 1 | 2015-01-27 | View Edit Delete | ||||||||||||
| 703203 | 78955 | MOMETASONA FUROATO KERN PHARMA 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA FUROATO KERN PHARMA 50 MICROGRAMOS SUSPENSION PARA PULVERIZACION NASAL , 18 g (140 pulverizaciones) | 50 microgramos/dosis | 6 | 140 | 31 | 18 g (140 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78955/78955_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78955/78955_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2014-07-29 | 1 | 1 | 1 | 2014-07-29 | 2014-07-29 | 1 | 2015-08-04 | View Edit Delete | ||||||||||||
| 704482 | 79267 | MOMETASONA FUROATO STADA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | MOMETASONA FUROATO STADA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL , 18 g (140 pulverizaciones) | 50 microgramos/dosis | 6 | 140 | 31 | 18 g (140 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79267/79267_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79267/79267_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2014-12-02 | 1 | 1 | 1 | 2014-12-02 | 2014-12-05 | 1 | 2015-06-04 | View Edit Delete | ||||||||||||
| 705672 | 79618 | MAGNESIA SEID 2,4 G POLVO PARA SUSPENSION ORAL | MAGNESIA SEID 2,4 G POLVO PARA SUSPENSION ORAL , 14 sobres | 2.400 mg | 35 | 14 | 64 | 14 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79618/79618_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79618/79618_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2599 | 2599 | 2015-03-09 | 1 | 1 | 1 | 2015-03-09 | 2015-03-09 | 1 | 2015-10-29 | View Edit Delete | ||||||||||||
| 706118 | 79724 | MAGNESIA LAINCO 200 MG/ML SUSPENSION ORAL | MAGNESIA LAINCO 200 MG/ML SUSPENSION ORAL , 220 ml | 200 mg/ml | 6 | 220 | 26 | 220 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79724/79724_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79724/79724_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | 1614 | 2015-04-10 | 1 | 1 | 1 | 2015-04-10 | 2015-04-10 | 1 | 2016-10-11 | View Edit Delete | ||||||||||||
| 706809 | 79947 | RHINOVIN ALERGIA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | RHINOVIN ALERGIA 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL, 60 pulverizaciones | 50 microgramos/dosis | 6 | 60 | 31 | 60 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79947/79947_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79947/79947_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71217 | 71217 | 2016-05-27 | 1 | 1 | 1 | 2016-05-27 | 2016-05-27 | 1 | 2016-12-21 | View Edit Delete | ||||||||||||
| 708586 | 64730 | RHINOCORT 64 microgramos SUSPENSION PARA PULVERIZACION NASAL | RHINOCORT 64 microgramos SUSPENSION PARA PULVERIZACION NASAL, 1 envase pulverizador de 120 dosis | 64 microgramos/dosis | 34 | 120 | 31 | 1 envase pulverizador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64730/64730_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64730/64730_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | 68780 | 2002-04-26 | 1 | 1 | 1 | 2002-04-26 | 2004-05-10 | 1 | 2011-10-24 | 727545 | View Edit Delete | |||||||||||
| 709756 | 80572 | NASOALDO 50 microgramos/pulsación suspensión para pulverización nasal | NASOALDO 50 microgramos/pulsación suspensión para pulverización nasal , 140 dosis | 50 microgramos/dosis | 6 | 140 | 30 | 140 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80572/80572_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80572/80572_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2016-01-22 | 1 | 1 | 1 | 2016-01-22 | 2016-01-22 | 1 | 2016-06-15 | View Edit Delete | ||||||||||||
| 711185 | 58329 | ALMAX FORTE 1,5 g SUSPENSION ORAL | ALMAX FORTE 1,5 g SUSPENSION ORAL,12 sobres | 1,5 g | 35 | 12 | 64 | 12 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58329/58329_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58329/58329_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 1989-12-01 | 1 | 1 | 1 | 1989-12-01 | 2016-06-10 | 1 | 2016-10-01 | View Edit Delete | ||||||||||||
| 711187 | 58329 | ALMAX FORTE 1,5 g SUSPENSION ORAL | ALMAX FORTE 1,5 g SUSPENSION ORAL,24 sobres | 1,5 g | 35 | 24 | 64 | 24 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58329/58329_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58329/58329_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 88187 | 1989-12-01 | 1 | 1 | 1 | 1989-12-01 | 2016-06-10 | 1 | 2016-10-01 | View Edit Delete | ||||||||||||
| 713580 | 81427 | SEVELAMERO STADA 2,4 G POLVO PARA SUSPENSION ORAL | SEVELAMERO STADA 2,4 G POLVO PARA SUSPENSION ORAL, 90 sobres | 2.400 mg | 35 | 90 | 64 | 90 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81427/81427_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81427/81427_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2017-03-22 | 1 | 1 | 1 | 2017-03-22 | 2017-03-22 | 1 | 2017-11-07 | View Edit Delete | ||||||||||||
| 715520 | 81921 | SEVELAMERO KERN PHARMA 2,4 G POLVO PARA SUSPENSION ORAL | SEVELAMERO KERN PHARMA 2,4 G POLVO PARA SUSPENSION ORAL 90 sobres | 2,4 g | 35 | 90 | 64 | 90 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81921/81921_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81921/81921_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2017-04-03 | 1 | 1 | 1 | 2017-04-04 | 2017-04-03 | 1 | 2017-12-14 | View Edit Delete | ||||||||||||
| 718837 | 82399 | SEVELAMERO TEVA-RATIOPHARM 2,4 G POLVO PARA SUSPENSION ORAL | SEVELAMERO TEVA-RATIOPHARM 2,4 G POLVO PARA SUSPENSION ORAL, 90 Sobres | 2.400 mg | 35 | 90 | 64 | 90 Sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82399/82399_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82399/82399_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2017-09-11 | 1 | 1 | 1 | 2017-09-12 | 2017-09-11 | 1 | 2018-03-14 | View Edit Delete | ||||||||||||
| 718838 | 82400 | SEVELAMERO RATIOPHARM 2,4 G POLVO PARA SUSPENSION ORAL | SEVELAMERO RATIOPHARM 2,4 G POLVO PARA SUSPENSION ORAL, 90 Sobres | 2.400 mg | 35 | 90 | 64 | 90 Sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82400/82400_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82400/82400_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2017-09-11 | 1 | 1 | 1 | 2017-09-12 | 2017-09-11 | 1 | 2018-03-14 | View Edit Delete | ||||||||||||
| 720445 | 82795 | MOMCORT 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL | MOMCORT 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL, 140 pulverizaciones | 50 microgramos/dosis | 6 | 140 | 31 | 140 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82795/82795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82795/82795_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2018-01-15 | 1 | 1 | 1 | 2018-01-16 | 2018-01-15 | 1 | 2018-07-10 | View Edit Delete | ||||||||||||
| 720625 | 82846 | FOSQUEL 2,4 G POLVO PARA SUSPENSION ORAL | FOSQUEL 2,4 G POLVO PARA SUSPENSION ORAL, 90 sobres | 2.400 mg | 35 | 90 | 64 | 90 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82846/82846_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82846/82846_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2495 | 2495 | 2018-02-21 | 1 | 1 | 1 | 2018-02-21 | 2018-02-21 | 1 | 2018-10-22 | View Edit Delete | ||||||||||||
| 723436 | 112776024 | FYCOMPA 0,5 MG/ML SUSPENSION ORAL | FYCOMPA 0,5 MG/ML SUSPENSION ORAL , 1 frasco de 340 ml | 0,5 mg/ml | 6 | 340 | 26 | 1 frasco de 340 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112776024/112776024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112776024/112776024_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34732 | 32215 | 2018-09-25 | 1 | 1 | 1 | 2018-09-26 | 2018-09-25 | 1 | 2019-09-02 | View Edit Delete | ||||||||||||
| 724795 | R-2948IP | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL | FLIXONASE 50 microgramos/pulverizacion, SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 dosis | 50 microgramos | 6 | 120 | 30 | 1 frasco de 120 dosis | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30289 | 43579 | 2019-02-14 | 1 | 1 | 1 | 2019-02-15 | 2019-02-14 | 1 | 2026-03-27 | View Edit Delete | ||||||||||||
| 724796 | 3400927563119 | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, frasco de 23 g (120 pulverizaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | frasco de 23 g (120 pulverizaciones) | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400927563119/3400927563119_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28538 | 43579 | 2019-02-14 | 1 | 1 | 1 | 2019-02-15 | 2019-02-14 | 1 | 2023-09-05 | View Edit Delete | ||||||||||||
| 725901 | 68584 | BUDENA 64 microgramos SUSPENSION PARA PULVERIZACION NASAL | BUDENA 64 microgramos SUSPENSION PARA PULVERIZACION NASAL,1 envase pulverizador de 200 dosis | 64 microgramos/dosis | 6 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68584/68584_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68584/68584_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2007-03-08 | 1 | 1 | 1 | 2015-10-21 | 2019-05-28 | 1 | 2021-05-17 | View Edit Delete | ||||||||||||
| 725902 | 68406 | BUDESONIDA ALDO-UNION 64 microgramos SUSPENSION PARA PULVERIZACION NASAL EFG | BUDESONIDA ALDO-UNION 64 microgramos SUSPENSION PARA PULVERIZACION NASAL EFG,1 envase pulverizador de 200 dosis | 64 microgramos/dosis | 6 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68406/68406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68406/68406_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2007-01-24 | 1 | 1 | 1 | 2007-01-24 | 2019-05-28 | 1 | 2019-10-15 | View Edit Delete | ||||||||||||
| 727346 | 84644 | ALGIDRIN PEDIATRICO 40 MG/ML SUSPENSION ORAL | ALGIDRIN PEDIATRICO 40 MG/ML SUSPENSION ORAL, 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84644/84644_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84644/84644_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | 27143 | 2019-11-14 | 1 | 1 | 1 | 2019-11-15 | 2019-11-14 | 1 | 2020-09-29 | View Edit Delete | ||||||||||||
| 730290 | 108472050 | XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL | XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL, 1 frasco de 2,625 g de granulado | 1 mg/ml | 6 | 2,625 | 21 | 1 frasco de 2,625 g de granulado | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/108472050/108472050_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/108472050/108472050_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26523 | 11424 | 2021-02-09 | 1 | 1 | 1 | 2021-02-10 | 2021-02-09 | 1 | 2022-05-30 | View Edit Delete | ||||||||||||
| 730292 | 108472050 | XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL | XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL, 1 frasco de 5,25 g de granulado | 1 mg/ml | 6 | 5,25 | 21 | 1 frasco de 5,25 g de granulado | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/108472050/108472050_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/108472050/108472050_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26523 | 11424 | 2021-02-09 | 1 | 1 | 1 | 2021-02-10 | 2021-02-09 | 1 | 2022-05-30 | View Edit Delete | ||||||||||||
| 731271 | 86059 | RYALTRIS 25 MICROGRAMOS/600 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL | RYALTRIS 25 MICROGRAMOS/600 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 30 ml (240 pulverizaciones) | 25 microgramos/600 microgramos/dosis | 6 | 240 | 31 | 1 frasco de 30 ml (240 pulverizaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86059/86059_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86059/86059_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10539 | 1803 | 2021-07-01 | 1 | 1 | 1 | 2021-07-02 | 2021-07-01 | 1 | 2022-12-12 | View Edit Delete | ||||||||||||
| 732451 | 3400927563119IP1 | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, frasco de 23 g (120 pulverizaciones) | 50 microgramos/137 microgramos | 6 | 120 | 31 | frasco de 23 g (120 pulverizaciones) | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30019 | 26669 | 2021-12-15 | 1 | 1 | 1 | 2021-12-16 | 2021-12-15 | 1 | 2022-02-11 | View Edit Delete | ||||||||||||
| 733342 | 86723 | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL, 120 dosis | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86723/86723_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86723/86723_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2022-03-31 | 1 | 1 | 1 | 2022-04-01 | 2022-03-31 | 1 | 2022-10-13 | View Edit Delete | ||||||||||||
| 737668 | 34551 | MAGNESIA CINFA 200 mg/ ml SUSPENSION ORAL | MAGNESIA CINFA 200 mg/ ml SUSPENSION ORAL, 1 frasco de 260 ml | 200 mg/ml | 6 | 260 | 26 | 1 frasco de 260 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/34551/34551_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/34551/34551_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 1960-10-01 | 1 | 1 | 1 | 1960-10-01 | 1960-10-01 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 738278 | 60537 | BUDESONIDA ALCON 100 microgramos/DOSIS SUSPENSION PARA PULVERIZACION NASAL | BUDESONIDA ALCON 100 microgramos/DOSIS SUSPENSION PARA PULVERIZACION NASAL, 1 envase pulverizador de 200 dosis | 100 microgramos/dosis | 6 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60537/60537_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60537/60537_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29808 | 945 | 1995-05-01 | 1 | 1 | 1 | 1995-05-01 | 1999-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 738328 | 59533 | BUDESONIDA ALCON 50 microgramos/DOSIS SUSPENSION PARA PULVERIZACION NASAL | BUDESONIDA ALCON 50 microgramos/DOSIS SUSPENSION PARA PULVERIZACION NASAL, 1 envase pulverizador de 200 dosis | 50 microgramos/dosis | 6 | 200 | 31 | 1 envase pulverizador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59533/59533_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59533/59533_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29808 | 945 | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 1999-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 763215 | R-2948IP2 | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 dosis | 50 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 dosis | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R-2948IP2/R-2948IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30289 | 23628 | 2023-07-31 | 1 | 1 | 1 | 2023-08-01 | 2023-07-31 | 1 | 2023-09-13 | View Edit Delete | ||||||||||||
| 764795 | 89519 | TUSSAL 35,4 MG JARABE EN SOBRES | TUSSAL 35,4 MG JARABE EN SOBRES, 20 sobres de 10 ml | 35,4 mg | 35 | 20 | 64 | 20 sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89519/89519_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89519/89519_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2024-04-25 | 1 | 1 | 1 | 2024-04-26 | 2024-04-25 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 766765 | 80572 | NASOALDO 50 microgramos/pulsación suspensión para pulverización nasal | NASOALDO 50 microgramos/pulsación suspensión para pulverización nasal, 115 dosis | 50 microgramos/dosis | 6 | 115 | 31 | 115 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80572/80572_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80572/80572_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2016-01-22 | 1 | 1 | 1 | 2016-01-22 | 2025-01-28 | 1 | 2025-03-31 | View Edit Delete | ||||||||||||
| 767539 | 90298 | AVANCORT DUO 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | AVANCORT DUO 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 23 g (120 aplicaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 23 g (120 aplicaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90298/90298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90298/90298_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2025-04-28 | 1 | 1 | 1 | 2025-04-30 | 2025-04-28 | 1 | 2025-11-13 | View Edit Delete | ||||||||||||
| 769820 | 86723 | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL, 100 dosis | 50 microgramos/137 microgramos/dosis | 6 | 100 | 31 | 100 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86723/86723_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86723/86723_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2022-03-31 | 1 | 1 | 1 | 2022-04-01 | 2026-02-02 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 769821 | 86723 | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL | RINODUO 137 MICROGRAMOS/50 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL, 150 dosis | 50 microgramos/137 microgramos/dosis | 6 | 150 | 31 | 150 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86723/86723_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86723/86723_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | 16620 | 2022-03-31 | 1 | 1 | 1 | 2022-04-01 | 2026-02-02 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 769954 | 3400937412865 | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL | FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 120 dosis | 50 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 120 dosis | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400937412865/3400937412865_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29137 | 43579 | 2026-02-18 | 1 | 1 | 1 | 2026-02-19 | 2026-02-18 | 1 | 2026-03-27 | View Edit Delete | ||||||||||||
| 793919 | 57849 | FLUTOX 3,54 mg/ml JARABE | FLUTOX 3,54 mg/ml JARABE , 1 frasco de 120 ml | 3,54 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57849/57849_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57849/57849_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29563 | 29563 | 1988-12-01 | 1 | 1 | 1 | 1988-12-01 | 1999-04-01 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 926253 | 64111 | AMOXICILINA/ACIDO CLAVULANICO NORMON 125 mg/31,25 mg/5 ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA/ACIDO CLAVULANICO NORMON 125 mg/31,25 mg/5 ml POLVO PARA SUSPENSION ORAL EFG, 1 frasco de 120 ml | 125 mg/5 ml + 31,25 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64111/64111_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64111/64111_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2001-07-23 | 1 | 1 | 1 | 2001-07-23 | 2001-07-23 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 946582 | 55411 | MOTILIUM 1 mg/ml SUSPENSION ORAL | MOTILIUM 1 mg/ml SUSPENSION ORAL, 1 frasco de 200 ml | 1 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/55411/55411_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/55411/55411_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29206 | 29206 | 1981-03-01 | 1 | 1 | 1 | 1981-03-01 | 1981-03-01 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 960047 | 56281 | SEKISAN 3,54 mg/ml JARABE | SEKISAN 3,54 mg/ml JARABE , 1 frasco de 120 ml | 3,54 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56281/56281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56281/56281_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | 945 | 1984-05-29 | 1 | 1 | 1 | 1984-05-29 | 1984-05-29 | 1 | 2012-01-02 | View Edit Delete |